← Evidence map

ArticleBiomolecules2022

APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.

James Andrew McCubrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35204775